These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9861280)

  • 1. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings.
    Ogbuagu KF; Eneanya CI
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S139-45. PubMed ID: 9861280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial.
    Brieger WR; Awedoba AK; Eneanya CI; Hagan M; Ogbuagu KF; Okello DO; Ososanya OO; Ovuga EB; Noma M; Kale OO; Burnham GM; Remme JH
    Trop Med Int Health; 1998 Dec; 3(12):951-61. PubMed ID: 9892280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
    Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
    Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
    Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
    Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
    al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
    Sante; 1997; 7(6):391-5. PubMed ID: 9503497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special intervention zones.
    Yaméogo L
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():23-4. PubMed ID: 18718150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria.
    Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC
    Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onchocercal eye disease and the impact of Mectizan treatment.
    Abiose A
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
    Brieger WR; Kale OO; Ososanya OO
    Trop Doct; 2001 Apr; 31(2):96-8. PubMed ID: 11321284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of amenorrhoea after Mectizan treatment.
    Anosike JC; Abanobi OC
    Trop Geogr Med; 1995; 47(5):222-4. PubMed ID: 8553449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeated community-based ivermectin treatment on the intensity of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Rural Remote Health; 2003; 3(2):211. PubMed ID: 15877511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delivery of ivermectin (Mectizan).
    Burnham G; Mebrahtu T
    Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human onchocerciasis and "sowda" in the Republic of Yemen].
    Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
    Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
    Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
    J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin--clinical trials and treatment schedules in onchocerciasis.
    Brown KR; Neu DC
    Acta Leiden; 1990; 59(1-2):169-75. PubMed ID: 2198749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New light shed on the importance and care of onchocercal skin disease.
    TDR News; 1998 Feb; (55):5. PubMed ID: 12348563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.